WELLINGTON MANAGEMENT GROUP LLP - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 141 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2023$1,209,423
-68.4%
5,227
-66.9%
0.00%
-100.0%
Q1 2023$3,830,373
-58.5%
15,811
-50.3%
0.00%
-50.0%
Q4 2022$9,238,657
+488.1%
31,830
+31.7%
0.00%
Q3 2022$1,571,000
-10.1%
24,176
-1.0%
0.00%
Q2 2022$1,748,000
-98.0%
24,419
-97.3%
0.00%
-100.0%
Q1 2022$88,434,000
-21.0%
901,290
-31.8%
0.02%
-16.7%
Q4 2021$111,925,000
+37.8%
1,320,795
+29.7%
0.02%
+28.6%
Q3 2021$81,228,000
-3.9%
1,018,018
+17.3%
0.01%0.0%
Q2 2021$84,529,000
-11.5%
867,766
+6.2%
0.01%
-17.6%
Q1 2021$95,546,000
-6.2%
816,834
-10.8%
0.02%
-10.5%
Q4 2020$101,819,000
+8.6%
915,892
+15.9%
0.02%0.0%
Q3 2020$93,785,000
-1.3%
789,903
-5.8%
0.02%
-9.5%
Q2 2020$95,015,000
+62.9%
838,981
-4.0%
0.02%
+40.0%
Q1 2020$58,343,000
-33.1%
873,915
-8.7%
0.02%
-16.7%
Q4 2019$87,205,000
+20.1%
957,146
+13.7%
0.02%
+12.5%
Q3 2019$72,610,000
+740.1%
842,147
+921.2%
0.02%
+700.0%
Q2 2019$8,643,000
-1.2%
82,464
+18.1%
0.00%0.0%
Q1 2019$8,748,000
+8.7%
69,842
-2.2%
0.00%0.0%
Q4 2018$8,050,000
-9.7%
71,418
+71.6%
0.00%0.0%
Q3 2018$8,914,000
+1134.6%
41,631
+1511.7%
0.00%
Q2 2018$722,0002,5830.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
University of Wisconsin Foundation 73,487$17,003,42228.29%
Tao Capital Management LP 130,529$30,20227.63%
Paulson & Co. 1,105,741$255,846,35323.09%
AlpInvest Partners B.V. 211,488$48,934,09311.18%
Bain Capital Life Sciences Investors, LLC 324,619$75,110,3447.20%
Avoro Capital Advisors LLC 1,888,888$437,050,9056.04%
Propel Bio Management, LLC 30,032$6,948,8045.76%
Baker Brothers Advisors 1,969,798$455,771,8615.19%
Rosalind Advisors, Inc. 25,000$5,784,5004.76%
TCG Crossover Management, LLC 179,917$41,629,1954.62%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders